Things have changed at the Convention for Biological Diversity, CBD, says Jim Thomas who participated in most of the Convention’s COPs (CBD Conference of Parties) and MOPs (Meeting of Parties to the CBDs Biosafety Protocol) in this century.
As biotechnology reaches ever greater capabilities to “re-design” nature, some want to turn the CBD into a place for the promotion rather than regulation of biotechnology. Parties to the Convention cannot let this happen, warns German-based NGO Save Our Seeds.
As scientists and environmentalists grapple with synthetic biology, a crucial debate failed to materialize at the IUCN regional meeting in Bruges, Belgium. Instead, the meeting revealed significant concerns about the organization’s policy development process on synthetic biology and its implications for nature conservation.
At the 26th Meeting of the Subsidiary Body on Scientific, Technical and Technological Advice (SBSTTA) to the Convention of Biological Diversity (CBD), Gene Drives received significant attention.
